a year ago
LNTH
AnalystsJustin WalshJustin Walsh's Stock Forecasts
AnalystsJustin Walsh
Analyst Ranking
Bottom 3%
#4794 out of 4929 analysts
Average Return
-9.01%
Win Rate
34%13 out of 38
Risk vs Reward
Poor
Good
Justin Walsh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Harrow IncHROW | +261.36% | $5.90 | $21.32 | 2022-05-20 - 2023-05-19 | Strong Buy |
Perspective Therapeutics IncCATX | +254.25% | $2.52 | $8.92 | 2023-11-15 - 2024-11-14 | Strong Buy |
Lantheus Holdings IncLNTH | +70.72% | $55.54 | $94.82 | 2022-05-09 - 2023-05-08 | Strong Buy |
Lantheus Holdings IncLNTH | +62.55% | $62.33 | $101.32 | 2024-04-18 - 2025-04-17 | Strong Buy |
Lantheus Holdings IncLNTH | +58.54% | $59.29 | $94.00 | 2024-01-10 - 2025-01-08 | Strong Buy |
Justin Walsh Analyst Color
Get additional color on Justin Walsh's coverage of popular stocks
a year ago
LNTH
a year ago
CATX
a year ago
LNTH
Justin Walsh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lantheus Holdings IncLNTH | 9 | Strong Buy | $109.00 | +35.54% | Maintains | 11 days ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $3.00 | +305.41% | Initiates Coverage On | 24 days ago |
Biolinerx LtdBLRX | 2 | Strong Buy | $12.00 | +167.26% | Upgrades | a month ago |
Clene IncCLNN | 1 | Strong Buy | $30.00 | +669.23% | Initiates Coverage On | 2 months ago |
Serina Therapeutics IncSER | 1 | Strong Buy | $11.00 | +85.19% | Initiates Coverage On | 4 months ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $18.00 | +665.96% | Initiates Coverage On | 7 months ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $42.00 | +248.84% | Initiates Coverage On | 9 months ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $23.00 | +434.88% | Initiates Coverage On | a year ago |
Perspective Therapeutics IncCATX | 2 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Trisalus Life Sciences IncTLSI | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Cytosorbents CorpCTSO | 2 | Strong Buy | $4.00 | N/A | Reinstates | 2 years ago |
Prime Medicine IncPRME | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Theratechnologies IncTHTX | 1 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Vor Biopharma IncVOR | 2 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Viewray IncVRAYQ | 2 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $175.00 | N/A | Initiates Coverage On | 2 years ago |
Mainz Biomed NvMYNZ | 1 | Strong Buy | $440.00 | N/A | Initiates Coverage On | 2 years ago |
Plus Therapeutics IncPSTV | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Fusion Pharmaceuticals IncFUSN | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 3 years ago |
Point Biopharma Global IncPNT | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Harrow IncHROW | 1 | Strong Buy | $20.00 | N/A | Maintains | 3 years ago |
Curis IncCRIS | 2 | Strong Buy | $200.00 | N/A | Maintains | 3 years ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 3 years ago |
Portage Biotech IncPRTG | 1 | Strong Buy | $800.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.